Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

COMPOUNDS WITH MDR1-INVERSE ACTIVITY

  • Read more about COMPOUNDS WITH MDR1-INVERSE ACTIVITY
US Application 61/027,712
Filed on 2008-02-11

Concise Preparation Of New Unnatural, Functionalized Sugar Nucleotides With Vast Applications

  • Read more about Concise Preparation Of New Unnatural, Functionalized Sugar Nucleotides With Vast Applications
US Application 61/027,782
Filed on 2008-02-11

Novel Natural Product Inhibitors Of ABCG2 From The Developmental Therapeutics Program Compound Collection

  • Read more about Novel Natural Product Inhibitors Of ABCG2 From The Developmental Therapeutics Program Compound Collection
US Application 60/986,155
Filed on 2007-11-07

Novel Natural Product Inhibitors Of ABCG2

  • Read more about Novel Natural Product Inhibitors Of ABCG2
US Application 61/018,758
Filed on 2008-01-03

MiRNA Biomarkers Predict Esophageal Carcinoma Diagnosis And Barrett's Esophagus Status

  • Read more about MiRNA Biomarkers Predict Esophageal Carcinoma Diagnosis And Barrett's Esophagus Status
US Application 60/979,300
Filed on 2007-10-11

METHODS OF OBTAINING ANTIGEN-SPECIFIC T CELL POPULATIONS

  • Read more about METHODS OF OBTAINING ANTIGEN-SPECIFIC T CELL POPULATIONS
US Application 61/027,623
Filed on 2008-02-11

METHOD FOR OBTAINING THREE-DIMENSIONAL COMPOSITIONAL MAPS OF A BIOLOGICAL SAMPLE

  • Read more about METHOD FOR OBTAINING THREE-DIMENSIONAL COMPOSITIONAL MAPS OF A BIOLOGICAL SAMPLE
US Application 60/974,686
Filed on 2007-09-24

Treatment Of Pregname X Receptor (PXR) Related Disorders

  • Read more about Treatment Of Pregname X Receptor (PXR) Related Disorders
US Application 60/999,234
Filed on 2007-10-17

COMPOSITIONS AND METHODS FOR INHIBITION OF HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET SIGNALING

  • Read more about COMPOSITIONS AND METHODS FOR INHIBITION OF HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET SIGNALING
US Application 61/041,523
Filed on 2008-04-01

VIRAL INACTIVATION USING CROSSLINKERS AND DETERGENTS

  • Read more about VIRAL INACTIVATION USING CROSSLINKERS AND DETERGENTS
US Application 61/025,424
Filed on 2008-02-01

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 133
  • Page 134
  • Page 135
  • Page 136
  • Page 137
  • Page 138
  • Page 139
  • Page 140
  • Page 141
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health